Impactul infecției COVID-19 asupra afectării pulmonare la copilul cu fibroză chistică

Balanețchi, Ludmila; Șciuca, Svetlana

dc.contributor.author	Balanețchi, Ludmila
dc.contributor.author	Șciuca, Svetlana
dc.date.accessioned	2023-07-28T12:13:28Z
dc.date.available	2023-07-28T12:13:28Z
dc.date.issued	2023
dc.identifier.isbn	978-9975-82-328-9
dc.identifier.uri	https://repository.usmf.md/handle/20.500.12710/25188
dc.description.abstract	Pulmonary infections will remain the major prognostic problem in cystic fibrosis. COVID-19 is a highly dangerous pathogen for CF. Studies in Europe reported a 0,3% incidence of COVID-19 in CF. The pathogenesis of SARS-CoV-2 is directly intertwined and overlaps with that of CF. CF patients infected with COVID-19 would be at high risk of disease, with a more pronounced proinflammatory response and lung damage. There are no specific protocols for the management of CF patients with COVID-19. Vaccination against COVID-19 is encouraged. Scientific results show a relatively good recovery from COVID-19 in CF patients, the disease has similar manifestations to the general population.	en_US
dc.language.iso	ro	en_US
dc.publisher	CEP Medicina	en_US
dc.relation.ispartof	Culegerea de lucrări a Conferinței cu participare internațională „Actualități în pneumologia copilului”, 22 iunie 2023, Chișinău, Republica Moldova	en_US
dc.title	Impactul infecției COVID-19 asupra afectării pulmonare la copilul cu fibroză chistică	en_US
dc.title.alternative	Impact of COVID-19 infection on lung illness in children with cystic fibrosis	en_US
dc.type	Article	en_US